Revenue: The sum of all revenue fields included for a company's operating activities.
Taysha Gene Therapies, Inc. (TSHA) had Revenue of $1.99M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$1.99M |
$-26.88M |
|
-- |
|
$1.99M |
|
$28.74M |
|
$-26.75M |
|
$-0.13M |
|
$-26.88M |
|
$-26.88M |
|
$-26.88M |
|
$-26.88M |
|
$-26.88M |
|
$-26.88M |
|
$-26.75M |
|
$-26.48M |
|
297.99M |
|
297.99M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$316.26M |
|
$6.96M |
|
$17.07M |
|
$333.33M |
|
$25.35M |
|
$41.05M |
|
$59.26M |
|
$84.60M |
|
$248.73M |
|
$248.73M |
|
$248.73M |
|
272.73M |
|
| Cash Flow Statement Financials | |
$-42.20M |
|
$-0.31M |
|
$216.24M |
|
$141.64M |
|
$315.36M |
|
$173.72M |
|
$6.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.48 |
|
-- |
|
-- |
|
0.14 |
|
0.17 |
|
100.00% |
|
-1347.08% |
|
-1347.08% |
|
-- |
|
-1353.58% |
|
-1353.58% |
|
$-42.58M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-10.81% |
|
-10.81% |
|
-8.06% |
|
-9.28% |
|
$0.91 |
|
$-0.14 |
|
$-0.14 |
|